Position in NEO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$148,084,657
-$80,780,800 QoQ
Shares Held
19,957,502
+2.5% QoQ
Ownership
15.3%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BlackRock, Inc. holds $53,866,454,003 across 42 Diagnostics & Research names. NEO ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
30,427,192 | $14,955,877,673 | |
| 2 | DHR |
Danaher Corp /De/
|
51,640,619 | $9,791,061,354 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
8,365,553 | $4,700,520,563 | |
| 4 | A |
Agilent Technologies, Inc.
|
25,902,662 | $2,952,385,405 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
15,027,444 | $2,562,780,290 | |
| 6 | WAT |
Waters Corp /De/
|
8,543,014 | $2,544,109,560 | |
| 7 | ILMN |
Illumina, Inc.
|
19,023,590 | $2,344,847,691 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,771,002 | $2,233,587,712 |
All Filings in NEO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $148,084,657 | 19,957,502 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $228,865,457 | 19,461,349 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $148,987,723 | 19,298,929 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $141,993,731 | 19,424,588 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $188,513,397 | 19,864,426 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $333,615,625 | 20,243,667 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $293,692,302 | 19,911,343 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||